# Jonathan J. Taliercio

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jonathan-j-taliercio/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,668 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 24 |
| i10-index | 43 |
| Last Known Institution | Cleveland Clinic |
| OpenAlex ID | https://openalex.org/A5074001023 |
| ORCID iD | 0000-0003-4320-7151 |
| Works | 130 |

## Researcher papers

- [An atlas of healthy and injured cell states and niches in the human kidney](https://scholariq.org/papers/an-atlas-of-healthy-and-injured-cell-states-and-niches-in-the-human-kidney/)
- [Masked Hypertension and Elevated Nighttime Blood Pressure in CKD](https://scholariq.org/papers/masked-hypertension-and-elevated-nighttime-blood-pressure-in-ckd/)
- [Risk Factors for CKD Progression](https://scholariq.org/papers/risk-factors-for-ckd-progression/)
- [Therapeutic Advances in Diabetic Nephropathy](https://scholariq.org/papers/therapeutic-advances-in-diabetic-nephropathy/)
- [Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial](https://scholariq.org/papers/impact-of-primary-kidney-disease-on-the-effects-of-empagliflozin-in-patients/)
- [New Devices and Technologies for Hemodialysis Vascular Access: A Review](https://scholariq.org/papers/new-devices-and-technologies-for-hemodialysis-vascular-access-a-review/)
- [Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial](https://scholariq.org/papers/effects-of-empagliflozin-on-progression-of-chronic-kidney-disease-a-prespecified/)
- [Prognostic Importance of Serum Alkaline Phosphatase in CKD Stages 3-4 in a Clinical Population](https://scholariq.org/papers/prognostic-importance-of-serum-alkaline-phosphatase-in-ckd-stages-3-4-in-a/)
- [A New Panel-Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population](https://scholariq.org/papers/a-new-panel-estimated-gfr-including-2-microglobulin-and-trace-protein-and-not/)
- [Serum magnesium, mortality and disease progression in chronic kidney disease](https://scholariq.org/papers/serum-magnesium-mortality-and-disease-progression-in-chronic-kidney-disease/)
- [Clinical uptake of an antigen-based approach to membranous nephropathy: a survey of general nephrologists and glomerular disease experts](https://scholariq.org/papers/clinical-uptake-of-an-antigen-based-approach-to-membranous-nephropathy-a-survey/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)

## Researcher university

- [Cleveland Clinic](https://scholariq.org/institutions/cleveland-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.